Shaaltiel Yoseph

Avg. Two Year Performance

117% Avg. Purchase Return
47% Compound
21% Avg. Sale Return
10% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(8%)2%(54%)117%
Purchase Success Rate0 of 10 of 11 of 10 of 11 of 1
Average Sale Return1%2%(5%)10%21%
Sale Success Rate4 of 94 of 92 of 95 of 96 of 9
Drugs » Biotechnology

Executive VP, R&D:

Holdings: 795.92K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--